ID   IL4RA_RAT               Reviewed;         801 AA.
AC   Q63257; Q9R1W8; Q9WTM8;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   02-OCT-2024, entry version 174.
DE   RecName: Full=Interleukin-4 receptor subunit alpha;
DE            Short=IL-4 receptor subunit alpha;
DE            Short=IL-4R subunit alpha;
DE            Short=IL-4R-alpha;
DE            Short=IL-4RA;
DE   AltName: CD_antigen=CD124;
DE   Flags: Precursor;
GN   Name=Il4r; Synonyms=Il4ra;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Wistar; TISSUE=Spleen;
RX   PubMed=7640343; DOI=10.1006/cyto.1995.0027;
RA   Richter G., Hein G., Blankenstein T., Diamantstein T.;
RT   "The rat interleukin 4 receptor: coevolution of ligand and receptor.";
RL   Cytokine 7:237-241(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney;
RX   PubMed=10525162; DOI=10.1016/s0167-4889(99)00117-2;
RA   Chen G., Nagasawa R., Imasawa T., Eto Y., Kikuchi K., Maruyama N.;
RT   "Identification of soluble interleukin-4 receptor in rat glomerular
RT   epithelial cells.";
RL   Biochim. Biophys. Acta 1452:79-88(1999).
CC   -!- FUNCTION: Receptor for both interleukin 4 and interleukin 13. Couples
CC       to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in
CC       promoting Th2 differentiation. The IL4/IL13 responses are involved in
CC       regulating IgE production and, chemokine and mucus production at sites
CC       of allergic inflammation. In certain cell types, can signal through
CC       activation of insulin receptor substrates, IRS1/IRS2 (By similarity).
CC       {ECO:0000250}.
CC   -!- FUNCTION: Isoform 2 (soluble form) inhibits IL4-induced spleen cell
CC       proliferation.
CC   -!- SUBUNIT: The functional IL4 receptor is formed by initial binding of
CC       IL4 to IL4R. Subsequent recruitment to the complex of the common gamma
CC       chain, in immune cells, creates a type I receptor and, in non-immune
CC       cells, of IL13RA1 forms a type II receptor. IL4R can also interact with
CC       the IL13/IL13RA1 complex to form a similar type II receptor. Interacts
CC       with PIK3C3. Interacts with the SH2-containing phosphatases,
CC       PTPN6/SHIP1, PTPN11/SHIP2 and INPP5D/SHIP. Interacts with JAK1 through
CC       a Box 1-containing region; inhibited by SOCS5. Interacts with SOCS5;
CC       inhibits IL4 signaling. Interacts with JAK3. Interacts with CLM1.
CC       Interacts with IL13RA2. {ECO:0000250|UniProtKB:P16382,
CC       ECO:0000250|UniProtKB:P24394}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Membrane-bound form, mIL4R;
CC         IsoId=Q63257-1; Sequence=Displayed;
CC       Name=2; Synonyms=Soluble form, sIL4R;
CC         IsoId=Q63257-2; Sequence=VSP_011118, VSP_011119;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is expressed in kidney, spleen, lung and
CC       liver.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- PTM: On IL4 binding, phosphorylated on C-terminal tyrosine residues.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 4
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X69903; CAA49528.1; -; mRNA.
DR   EMBL; AB015746; BAA78337.1; -; mRNA.
DR   EMBL; AB015747; BAA78338.1; -; mRNA.
DR   PIR; S31575; S31575.
DR   RefSeq; NP_596871.2; NM_133380.2. [Q63257-1]
DR   RefSeq; XP_006230277.1; XM_006230215.3. [Q63257-1]
DR   RefSeq; XP_006230278.1; XM_006230216.2. [Q63257-1]
DR   RefSeq; XP_008758085.1; XM_008759863.2.
DR   RefSeq; XP_008758086.1; XM_008759864.2.
DR   RefSeq; XP_017444292.1; XM_017588803.1.
DR   RefSeq; XP_017444293.1; XM_017588804.1. [Q63257-1]
DR   AlphaFoldDB; Q63257; -.
DR   SMR; Q63257; -.
DR   STRING; 10116.ENSRNOP00000020994; -.
DR   GlyCosmos; Q63257; 5 sites, No reported glycans.
DR   GlyGen; Q63257; 5 sites.
DR   iPTMnet; Q63257; -.
DR   PhosphoSitePlus; Q63257; -.
DR   jPOST; Q63257; -.
DR   PaxDb; 10116-ENSRNOP00000020994; -.
DR   Ensembl; ENSRNOT00000020994.6; ENSRNOP00000020994.2; ENSRNOG00000015441.8. [Q63257-1]
DR   Ensembl; ENSRNOT00055053176; ENSRNOP00055043948; ENSRNOG00055030626. [Q63257-1]
DR   Ensembl; ENSRNOT00060055684; ENSRNOP00060046047; ENSRNOG00060032143. [Q63257-1]
DR   GeneID; 25084; -.
DR   KEGG; rno:25084; -.
DR   UCSC; RGD:2899; rat. [Q63257-1]
DR   AGR; RGD:2899; -.
DR   CTD; 3566; -.
DR   RGD; 2899; Il4r.
DR   eggNOG; ENOG502S3Y8; Eukaryota.
DR   GeneTree; ENSGT00510000049182; -.
DR   HOGENOM; CLU_020561_0_0_1; -.
DR   InParanoid; Q63257; -.
DR   OrthoDB; 5322153at2759; -.
DR   PhylomeDB; Q63257; -.
DR   TreeFam; TF337996; -.
DR   Reactome; R-RNO-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   PRO; PR:Q63257; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000015441; Expressed in ileum and 18 other cell types or tissues.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0004913; F:interleukin-4 receptor activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; TAS:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0042832; P:defense response to protozoan; ISO:RGD.
DR   GO; GO:0006955; P:immune response; TAS:RGD.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; ISO:RGD.
DR   GO; GO:0035771; P:interleukin-4-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0045626; P:negative regulation of T-helper 1 cell differentiation; ISO:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; ISO:RGD.
DR   GO; GO:0043032; P:positive regulation of macrophage activation; ISO:RGD.
DR   GO; GO:0043306; P:positive regulation of mast cell degranulation; ISO:RGD.
DR   GO; GO:1901741; P:positive regulation of myoblast fusion; ISO:RGD.
DR   GO; GO:0045630; P:positive regulation of T-helper 2 cell differentiation; ISO:RGD.
DR   GO; GO:0002532; P:production of molecular mediator involved in inflammatory response; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:1990834; P:response to odorant; IEP:RGD.
DR   GO; GO:0045063; P:T-helper 1 cell differentiation; ISO:RGD.
DR   GO; GO:0045064; P:T-helper 2 cell differentiation; ISO:RGD.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003531; Hempt_rcpt_S_F1_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR015319; IL-4_rcpt-alpha_N.
DR   PANTHER; PTHR23037; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR23037:SF32; INTERLEUKIN-4 RECEPTOR SUBUNIT ALPHA; 1.
DR   Pfam; PF09238; IL4Ra_N; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01355; HEMATOPO_REC_S_F1; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000250"
FT   CHAIN           26..801
FT                   /note="Interleukin-4 receptor subunit alpha"
FT                   /id="PRO_0000010892"
FT   TOPO_DOM        26..232
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        233..256
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        257..801
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          125..223
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          424..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          439..549
FT                   /note="Required for IRS1 activation and IL4-induced cell
FT                   growth"
FT                   /evidence="ECO:0000250"
FT   REGION          493..515
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          549..644
FT                   /note="Required for IL4-induced gene expression"
FT                   /evidence="ECO:0000250"
FT   REGION          767..801
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           212..216
FT                   /note="WSXWS motif"
FT   MOTIF           262..270
FT                   /note="Box 1 motif"
FT   MOTIF           698..703
FT                   /note="ITIM motif"
FT   COMPBIAS        425..465
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        493..507
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        782..801
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16382"
FT   MOD_RES         492
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P24394"
FT   MOD_RES         566
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P24394"
FT   MOD_RES         594
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P24394"
FT   MOD_RES         622
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P24394"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        128
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        162
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        176
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        34..44
FT                   /evidence="ECO:0000250"
FT   DISULFID        74..86
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         224..229
FT                   /note="HFQLPL -> PNNVNL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10525162"
FT                   /id="VSP_011118"
FT   VAR_SEQ         230..801
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10525162"
FT                   /id="VSP_011119"
FT   CONFLICT        3
FT                   /note="W -> R (in Ref. 1; CAA49528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        138
FT                   /note="A -> G (in Ref. 1; CAA49528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="S -> L (in Ref. 1; CAA49528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        580..582
FT                   /note="DAG -> ARW (in Ref. 1; CAA49528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        728
FT                   /note="S -> C (in Ref. 1; CAA49528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        776..777
FT                   /note="GK -> Q (in Ref. 1; CAA49528)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   801 AA;  86719 MW;  835E98D5E800EC76 CRC64;
     MGWLCTKFLS SVSCLILLWV TGSGGIKVLG DPTCFSDYIR TSTCEWQLDS TVDCSSQLLL
     DYRLLFEFSE NLTCTPKNSA DTVCVCQMAI EEPIQADTYW LELWSERGQL WQGSFKPSDN
     VKPPAPDNLT LHTNVSNALL LMWSNPYPSN NFLHKGLICM VNISREDNPA EFKVYNVTYT
     EPKLSFPVNT LTSGVRYRAR VRVLSQSFPG IWSEWSPSIT WYNHFQLPLL QRLPLGVSIS
     CICILLFCLT CYFSIIKIKK IWWDQIPTPA RSPLAAIIIQ DTKVSLWEKQ TRSQESTKSR
     HWKTCLTKLL PCLLEHRVKK ERESPKAAKT KPLQSPEKAG WYPAEVSRTV LWPENVHVSV
     VRCMELFEAP VQNVEEEEDE MVKGDLSMSP ENSGGGFQES QADIMARLTE NLFSDLLGAE
     NGGVGQSSMA ESSSLLPSES GQASTSWACF PTGPSETTCQ VTGQQPPHPD PERATGTACT
     QVPLVISDNP AYRSFSDFSS PAPNPGELAS EQKQAGHLEE GDLLSPVDPH SSGPPMQQAE
     SWEQILHMSV LQHGTAGSTP APTSGYQEFV QAVKQGASQD AGVPGVGPSG DTGYKAFSSL
     LSSSGVCTDT AAAGTDSGCG GYKPFQNPVP NQSPNSMPLF TFGLDMELPP SPLNSAPPNS
     TPECLGLELG LKGGTWLKAP PPSEQVPKPF GDDLGLGIVY SSLTCHLCGH LKQHHSQEED
     GQIHVVASPG CGCCYDEKSP SLGNLSGTLE SCPGEMSQEA NLTLAPRTPS NLSGVGKGPG
     HSPVPSQTTE VPVGTLGVTV S
//
